Is to engage RUF to provide independent stakeholder convening, scientific engagement, operational evaluation, research, and report preparation services in support of FDA's regulatory science and…
Active Definitive Contract Awarded Last action
- Contract number
- 75F40126C00214
- Awardee
-
Reagan-Udall Foundation For The Food And Drug Administration, Inc. UEI HJLEHGUWDF21
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $2,510,454
Award facts
- Opportunity
- Contract value 100% obligated
- $2,510,454.01 Current and potential, with all options
- Completion date 5% complete
- Current and potential, with all options
- NAICS code
- 813212 Voluntary Health Organizations
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Washington, DC 20036, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this award
The Food and Drug Administration awarded a $2.51 million firm fixed-price definitive contract to Reagan-Udall Foundation For The Food And Drug Administration, Inc. on September 30, 2026, on a sole-source basis.
RUF is authorized by the Food and Drug Administration Amendments Act of 2007 to receive FDA contracts and will provide independent stakeholder convening, scientific engagement, operational evaluation, research, and report preparation services supporting FDA's regulatory science and public health mission across 16 discrete projects. Work spans the Center for Devices and Radiological Health, Center for Drug Evaluation and Research, Office of Chief Scientist, Office of Cosmetics and Colors, and Human Foods Program. Project areas include transcranial ultrasound, rare disease diagnostics, medical device real-world evidence, cosmetics adverse events, generic drug quality, food inspection systems, nicotine and alcohol use disorders, buprenorphine products, pediatric exposure, cannabis messaging, and drug repurposing. Performance occurs at the contractor's Washington, D.C. facility, virtually, or as specified. The contract runs September 30, 2026 through September 29, 2027. RUF will execute work under the FDA's Pathways for Regulatory Innovation and Strategic Modernization (PRISM) framework, leveraging its demonstrated capacity to recruit expert panels, facilitate workshops and roundtables, conduct landscape reviews, and produce white papers.
Description
Is to engage RUF to provide independent stakeholder convening, scientific engagement, operational evaluation, research, and report preparation services in support of FDA's regulatory science and public health mission across 16 discrete project r
Quick answers
Who was awarded contract 75F40126C00214?
75F40126C00214 was awarded to Reagan-Udall Foundation For The Food And Drug Administration, Inc. by Food and Drug Administration (Department of Health and Human Services) on September 30, 2026.
How much is contract 75F40126C00214 worth?
The government has obligated $2,510,454 on 75F40126C00214.
Was contract 75F40126C00214 competed?
The extent of competition for 75F40126C00214 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award